| scholarly article | Q13442814 |
| P2093 | author name string | Alisa S Wolberg | |
| James R Byrnes | |||
| Sravya Kattula | |||
| P2860 | cites work | Extracellular DNA traps promote thrombosis. | Q24613579 |
| Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines | Q24633010 | ||
| Crystal structures of fragment D from human fibrinogen and its crosslinked counterpart from fibrin | Q27745853 | ||
| Disaggregation of in vitro preformed platelet-rich clots by abciximab increases fibrin exposure and promotes fibrinolysis | Q28174999 | ||
| Fibrinogen biosynthesis. Assembly, intracellular degradation, and association with lipid synthesis and secretion | Q28207376 | ||
| Blood coagulation factors V and VIII: structural and functional similarities and their relationship to hemorrhagic and thrombotic disorders | Q28290916 | ||
| Venous thrombosis | Q89217812 | ||
| Antithrombin-independent effects of heparins on fibrin clot nanostructure. | Q53656559 | ||
| Contribution of erythrocytes to thrombin generation in whole blood. | Q53891649 | ||
| Influence of gamma' fibrinogen splice variant on fibrin physical properties and fibrinolysis rate. | Q53909571 | ||
| Analyzing fibrin clot structure using a microplate reader. | Q53961092 | ||
| Compaction of fibrin clots reveals the antifibrinolytic effect of factor XIII. | Q54458544 | ||
| Flow profoundly influences fibrin network structure: implications for fibrin formation and clot stability in haemostasis. | Q55716954 | ||
| A Genome Search for Genetic Determinants That Influence Plasma Fibrinogen Levels | Q59590823 | ||
| Elevated prothrombin results in clots with an altered fiber structure: a possible mechanism of the increased thrombotic risk | Q61405268 | ||
| Altered Plasma Fibrin Clot Properties Are Associated With In-Stent Thrombosis | Q61930566 | ||
| Rheological properties of fibrin clots. Effects of fibrinogen concentration, Factor XIII deficiency, and Factor XIII inhibition | Q67316135 | ||
| A photometric assay for blood coagulation factor XIII | Q67943898 | ||
| Fibrinogen, cigarette smoking, and risk of cardiovascular disease: insights from the Framingham Study | Q68979773 | ||
| Effect of temperature, pH and ionic strength and composition on fibrin network structure and its development | Q69558040 | ||
| Increased resistance to plasmic degradation of fibrin with highly crosslinked alpha-polymer chains formed at high factor XIII concentrations | Q70051606 | ||
| Fibrin polymerization sites in fibrinogen and fibrin fragments | Q70907697 | ||
| The role of sialic acid in the dysfibrinogenemia associated with liver disease: distribution of sialic acid on the constituent chains | Q71702767 | ||
| Fibrin in human plasma: gel architectures governed by rate and nature of fibrinogen activation | Q72887288 | ||
| Interaction of fibrin(ogen) with heparin: further characterization and localization of the heparin-binding site | Q73561382 | ||
| The amino acid sequence in fibrin responsible for high affinity thrombin binding | Q73769028 | ||
| Elevated plasma fibrinogen gamma' concentration is associated with myocardial infarction: effects of variation in fibrinogen genes and environmental factors | Q79690468 | ||
| Thrombosis risk modification in transgenic mice containing the human fibrinogen thrombin-binding gamma' chain sequence | Q79786324 | ||
| gammaA/gamma' fibrinogen inhibits thrombin-induced platelet aggregation | Q79804224 | ||
| Bivalent binding to gammaA/gamma'-fibrin engages both exosites of thrombin and protects it from inhibition by the antithrombin-heparin complex | Q80137272 | ||
| Fibrinogen gamma' in ischemic stroke: a case-control study | Q80604991 | ||
| Genetic variation in the fibrinogen gamma gene increases the risk for deep venous thrombosis by reducing plasma fibrinogen gamma' levels | Q81168187 | ||
| Altered fibrin clot structure/function in patients with idiopathic venous thromboembolism and in their relatives | Q84426916 | ||
| Visualization of fibrinogen αC regions and their arrangement during fibrin network formation by high-resolution AFM | Q85956392 | ||
| Zinc promotes clot stability by accelerating clot formation and modifying fibrin structure | Q86532282 | ||
| Neutrophil extracellular traps promote thrombin generation through platelet-dependent and platelet-independent mechanisms | Q87381493 | ||
| Factor XI regulates pathological thrombus formation on acutely ruptured atherosclerotic plaques | Q88115305 | ||
| Rare and low-frequency variants and their association with plasma levels of fibrinogen, FVII, FVIII, and vWF | Q28607764 | ||
| Factor XIII: novel structural and functional aspects | Q30156007 | ||
| Oxidative modification of fibrinogen is associated with altered function and structure in the subacute phase of myocardial infarction. | Q30362121 | ||
| Polyphosphate delays fibrin polymerisation and alters the mechanical properties of the fibrin network | Q30834726 | ||
| Endothelial cells organize fibrin clots into structures that are more resistant to lysis | Q33220815 | ||
| Plasma fibrinogen gamma' chain content in the thrombotic microangiopathy syndrome. | Q33372953 | ||
| Cellular procoagulant activity dictates clot structure and stability as a function of distance from the cell surface | Q33381505 | ||
| Platelet Control of Fibrin Distribution and Microelasticity in Thrombus Formation Under Flow. | Q33429805 | ||
| Regulation of fibrinogen production by microRNAs | Q33613443 | ||
| The fibrinogen γA/γ' isoform does not promote acute arterial thrombosis in mice | Q33902971 | ||
| Abnormal plasma clot structure and stability distinguish bleeding risk in patients with severe factor XI deficiency | Q33934481 | ||
| Factor XIII activity mediates red blood cell retention in venous thrombi | Q33944224 | ||
| Lytic resistance of fibrin containing red blood cells. | Q33954228 | ||
| Factor XI deficiency in Ashkenazi Jews in Israel | Q34118794 | ||
| A systems approach to hemostasis: 3. Thrombus consolidation regulates intrathrombus solute transport and local thrombin activity | Q34170399 | ||
| Structural origins of fibrin clot rheology | Q34171813 | ||
| Fibrin-targeted magnetic resonance imaging allows in vivo quantification of thrombus fibrin content and identifies thrombi amenable for thrombolysis. | Q34333548 | ||
| A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. | Q34407258 | ||
| Thrombin generation and fibrin clot structure | Q34598931 | ||
| Molecular mechanisms affecting fibrin structure and stability | Q34759786 | ||
| Hindered dissolution of fibrin formed under mechanical stress | Q34976261 | ||
| Causal relationship between hyperfibrinogenemia, thrombosis, and resistance to thrombolysis in mice | Q35001664 | ||
| Factor XI antisense oligonucleotide for prevention of venous thrombosis | Q35200286 | ||
| 2013 scientific sessions Sol Sherry distinguished lecture in thrombosis: polyphosphate: a novel modulator of hemostasis and thrombosis. | Q35637441 | ||
| Relationship of cigarette smoking with inflammation and subclinical vascular disease: the Multi-Ethnic Study of Atherosclerosis | Q35794217 | ||
| A model of fibrin formation based on crystal structures of fibrinogen and fibrin fragments complexed with synthetic peptides | Q35837087 | ||
| Procoagulant changes in fibrin clot structure in patients with cirrhosis are associated with oxidative modifications of fibrinogen | Q35911484 | ||
| Multisite Thrombus Imaging and Fibrin Content Estimation With a Single Whole-Body PET Scan in Rats | Q36093873 | ||
| Factor XIIIa-dependent retention of red blood cells in clots is mediated by fibrin α-chain crosslinking | Q36169271 | ||
| Association of Plasma γ' Fibrinogen With Incident Cardiovascular Disease: The Atherosclerosis Risk in Communities (ARIC) Study | Q36326804 | ||
| Circulating Microparticles Alter Formation, Structure, and Properties of Fibrin Clots. | Q36346156 | ||
| Prothrombin activation in blood coagulation: the erythrocyte contribution to thrombin generation | Q36370881 | ||
| The role of recombinant factor VIIa (FVIIa) in fibrin structure in the absence of FVIII/FIX. | Q45863825 | ||
| High dose factor VIIa improves clot structure and stability in a model of haemophilia B. | Q45889198 | ||
| Effects of cigarette smoke exposure on clot dynamics and fibrin structure: an ex vivo investigation | Q46047915 | ||
| B:b interactions are essential for polymerization of variant fibrinogens with impaired holes 'a'. | Q46961100 | ||
| Fibrinogen gamma' chain carboxy terminal peptide selectively inhibits the intrinsic coagulation pathway | Q46970925 | ||
| Demonstration of a large molecular weight variant of the gamma chain of normal human plasma fibrinogen | Q47293932 | ||
| Clot architecture is altered in abdominal aortic aneurysms and correlates with aneurysm size | Q47355292 | ||
| Impact of procoagulant concentration on rate, peak and total thrombin generation in a model system | Q47979978 | ||
| In vitro activation of coagulation by human neutrophil DNA and histone proteins but not neutrophil extracellular traps. | Q48020432 | ||
| Structure of the human gamma-fibrinogen gene. Alternate mRNA splicing near the 3' end of the gene produces gamma A and gamma B forms of gamma-fibrinogen. | Q48386755 | ||
| .gamma. and .gamma.' chains of human fibrinogen are produced by alternative mRNA processing | Q48388090 | ||
| Contraction of Blood Clots Is Impaired in Acute Ischemic Stroke. | Q48409860 | ||
| Association of gammaA/gamma' fibrinogen levels and coronary artery disease. | Q50277146 | ||
| Fibrin network structure and clot mechanical properties are altered by incorporation of erythrocytes. | Q50590954 | ||
| The effect of red blood cells on thrombin generation. | Q50736139 | ||
| Modulation of protein C activation by histones, platelet factor 4, and heparinoids: new insights into activated protein C formation. | Q51774494 | ||
| Evidence that fibrinogen γ' directly interferes with protofibril growth: implications for fibrin structure and clot stiffness. | Q52623827 | ||
| Thrombin and fibrinogen γ' impact clot structure by marked effects on intrafibrillar structure and protofibril packing. | Q52820087 | ||
| Interactions between factor XIII and the alphaC region of fibrinogen. | Q52846367 | ||
| Genetic regulation of fibrin structure and function: complex gene-environment interactions may modulate vascular risk. | Q52860275 | ||
| Fibrinogen gamma-chain splice variant gamma' alters fibrin formation and structure. | Q52860374 | ||
| Altered fibrin clot structure in the healthy relatives of patients with premature coronary artery disease. | Q52861080 | ||
| Human plasma fibrinogen heterogeneity: evidence for an extended carboxyl-terminal sequence in a normal gamma chain variant (gamma'). | Q36404689 | ||
| Kinetics and mechanics of clot contraction are governed by the molecular and cellular composition of the blood | Q36443112 | ||
| A meta-analysis of 120 246 individuals identifies 18 new loci for fibrinogen concentration | Q36468916 | ||
| Coagulation Factor XI Promotes Distal Platelet Activation and Single Platelet Consumption in the Bloodstream Under Shear Flow. | Q36619746 | ||
| Prognostic utility and characterization of cell-free DNA in patients with severe sepsis | Q36634005 | ||
| Factor XI Deficiency Protects Against Atherogenesis in Apolipoprotein E/Factor XI Double Knockout Mice. | Q36672353 | ||
| Structure of fibrin: impact on clot stability | Q36884345 | ||
| Polyphosphate enhances fibrin clot structure | Q36915892 | ||
| Factor XI as a Therapeutic Target. | Q37033749 | ||
| Prevention of vascular graft occlusion and thrombus-associated thrombin generation by inhibition of factor XI | Q37071138 | ||
| Mechanisms of venous thrombosis and resolution | Q37093456 | ||
| Elevated prothrombin promotes venous, but not arterial, thrombosis in mice. | Q37189156 | ||
| Alterations of fibrinogen structure in human disease | Q37232976 | ||
| Plasma DNA is Elevated in Patients with Deep Vein Thrombosis | Q37262537 | ||
| Contributions of extravascular and intravascular cells to fibrin network formation, structure, and stability | Q37450566 | ||
| Factor XI deficiency in humans | Q37561466 | ||
| Clot contraction: compression of erythrocytes into tightly packed polyhedra and redistribution of platelets and fibrin. | Q37623550 | ||
| Indications for catheter-directed thrombolysis in the management of acute proximal deep venous thrombosis. | Q37710929 | ||
| Global assays of hemostasis | Q38233155 | ||
| Dysfibrinogenemia: from molecular anomalies to clinical manifestations and management | Q38393653 | ||
| Transport physics and biorheology in the setting of hemostasis and thrombosis | Q38723930 | ||
| Factor XIII: Structure and Function. | Q38791095 | ||
| The Role of Fibrinogen and Factor XIII in Hemostasis, and the Identification and Treatment of Associated Disorders. | Q38845925 | ||
| Differential contributions of monocyte- and platelet-derived microparticles towards thrombin generation and fibrin formation and stability. | Q38905674 | ||
| Synergy Between Tissue Factor and Exogenous Factor XIa in Initiating Coagulation | Q38993151 | ||
| Prothrombotic Fibrin Clot Phenotype Is Associated With Recurrent Pulmonary Embolism After Discontinuation of Anticoagulant Therapy | Q39034967 | ||
| Alteration of blood clotting and lung damage by protamine are avoided using the heparin and polyphosphate inhibitor UHRA. | Q39051903 | ||
| The interaction between fibrinogen and zymogen FXIII-A2B2 is mediated by fibrinogen residues γ390-396 and the FXIII-B subunits | Q39453804 | ||
| Factor XIII A-Subunit V34L Variant Affects Thrombus Cross-Linking in a Murine Model of Thrombosis | Q40131303 | ||
| Clot Structure: A Potent Mortality Risk Factor in Patients on Hemodialysis | Q40393715 | ||
| Cell-Free DNA Modulates Clot Structure and Impairs Fibrinolysis in Sepsis | Q40940254 | ||
| Antithrombotic effect of antisense factor XI oligonucleotide treatment in primates | Q41811285 | ||
| Flow rate and fibrin fiber alignment | Q42089484 | ||
| Fibrin, γ'-fibrinogen, and transclot pressure gradient control hemostatic clot growth during human blood flow over a collagen/tissue factor wound | Q42557135 | ||
| Atomic force microscopy-based molecular recognition of a fibrinogen receptor on human erythrocytes | Q42929227 | ||
| Microvascular thrombosis, fibrinolysis, ischemic injury, and death after cerebral thromboembolism are affected by levels of circulating α2-antiplasmin | Q43018362 | ||
| Interaction of factor XIII subunits | Q44792819 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | thrombosis | Q261327 |
| P304 | page(s) | e13-e21 | |
| P577 | publication date | 2017-03-01 | |
| P1433 | published in | Arteriosclerosis, Thrombosis, and Vascular Biology | Q4797542 |
| P1476 | title | Fibrinogen and Fibrin in Hemostasis and Thrombosis. | |
| P478 | volume | 37 |
| Q97541073 | A contradictory action of procoagulant ficin by a fibrinolytic serine protease from Egyptian Ficus carica latex |
| Q49498166 | Blood will out: vascular contributions to Alzheimer's disease. |
| Q91962556 | Characterization of Dermal Stem Cells of Diabetic Patients |
| Q49495916 | Clinical Consequences and Molecular Bases of Low Fibrinogen Levels. |
| Q45871584 | Clot waveform analysis: Where do we stand in 2017? |
| Q47140323 | Fibrinogen and C-reactive protein score is a prognostic index for patients with hepatocellular carcinoma undergoing curative resection: a prognostic nomogram study |
| Q89678950 | Hemostasis in elderly patients with human immunodeficiency virus (HIV) infection-Cross-sectional study |
| Q96303601 | Hepatic Surgical Stress Promotes Systemic Immunothrombosis That Results in Distant Organ Injury |
| Q98906714 | Increased levels of histidine-rich glycoprotein are associated with the development of post-thrombotic syndrome |
| Q91660072 | Modulating the rate of fibrin formation and clot structure attenuates microvascular thrombosis in systemic inflammation |
| Q55052025 | Observation of Ultrafast Vibrational Energy Transfer in Fibrinogen and Fibrin Fibers. |
| Q48625690 | Peptide-based fibrin-targeting probes for thrombus imaging |
| Q90279580 | Protease Activity in Vascular Disease |
| Q99203763 | Recent advances in use of fresh frozen plasma, cryoprecipitate, immunoglobulins, and clotting factors for transfusion support in patients with hematologic disease |
Search more.